AbbVie Statistics
Share Statistics
AbbVie has 1.77B shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 1.77B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.77B |
| Failed to Deliver (FTD) Shares | 16.96K |
| FTD / Avg. Volume | 0.27% |
Short Selling Information
The latest short interest is 18.53M, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 18.53M |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 2.77 |
Valuation Ratios
The PE ratio is 56.34 and the forward PE ratio is 14.1. AbbVie 's PEG ratio is 0.18.
| PE Ratio | 56.34 |
| Forward PE | 14.1 |
| PS Ratio | 5.04 |
| Forward PS | 5.1 |
| PB Ratio | 26.45 |
| P/FCF Ratio | 12.42 |
| PEG Ratio | 0.18 |
Enterprise Valuation
AbbVie Inc. has an Enterprise Value (EV) of 320.56B.
| EV / Earnings | 65.92 |
| EV / Sales | 5.9 |
| EV / EBITDA | 18.52 |
| EV / EBIT | 25.13 |
| EV / FCF | 14.53 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 5.73.
| Current Ratio | 0.87 |
| Quick Ratio | 0.76 |
| Debt / Equity | 5.73 |
| Total Debt / Capitalization | 85.15 |
| Cash Flow / Debt | 0.38 |
| Interest Coverage | 5.74 |
Financial Efficiency
Return on equity (ROE) is 0.47% and return on capital (ROIC) is 14.25%.
| Return on Equity (ROE) | 0.47% |
| Return on Assets (ROA) | 0.04% |
| Return on Capital (ROIC) | 14.25% |
| Revenue Per Employee | 1.09M |
| Profits Per Employee | 97.26K |
| Employee Count | 50.00K |
| Asset Turnover | 0.4 |
| Inventory Turnover | 4.98 |
Taxes
| Income Tax | 1.38B |
| Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 11.76% in the last 52 weeks. The beta is 0.61, so AbbVie 's price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | 11.76% |
| 50-Day Moving Average | 180.87 |
| 200-Day Moving Average | 178.8 |
| Relative Strength Index (RSI) | 56.73 |
| Average Volume (20 Days) | 6.22M |
Income Statement
In the last 12 months, AbbVie had revenue of 54.32B and earned 4.86B in profits. Earnings per share was 2.73.
| Revenue | 54.32B |
| Gross Profit | 33.90B |
| Operating Income | 12.76B |
| Net Income | 4.86B |
| EBITDA | 17.31B |
| EBIT | 12.76B |
| Earnings Per Share (EPS) | 2.73 |
Balance Sheet
The company has 12.81B in cash and 59.38B in debt, giving a net cash position of -46.57B.
| Cash & Cash Equivalents | 12.81B |
| Total Debt | 59.38B |
| Net Cash | -46.57B |
| Retained Earnings | -1.00B |
| Total Assets | 143.42B |
| Working Capital | -15.28B |
Cash Flow
In the last 12 months, operating cash flow was 22.84B and capital expenditures -777.00M, giving a free cash flow of 22.06B.
| Operating Cash Flow | 22.84B |
| Capital Expenditures | -777.00M |
| Free Cash Flow | 22.06B |
| FCF Per Share | 12.48 |
Margins
Gross margin is 6.24K%, with operating and profit margins of 2.35K% and 895%.
| Gross Margin | 6.24K% |
| Operating Margin | 2.35K% |
| Pretax Margin | 1.15K% |
| Profit Margin | 895% |
| EBITDA Margin | 31.86% |
| EBIT Margin | 23.49% |
| FCF Margin | 40.62% |
Dividends & Yields
ABBV pays an annual dividend of $6.56, which amounts to a dividend yield of 3.66%.
| Dividend Per Share | $6.56 |
| Dividend Yield | 3.66% |
| Dividend Growth (YoY) | 10.81% |
| Payout Ratio | 227.78% |
| Earnings Yield | 1.51% |
| FCF Yield | 6.89% |
Analyst Forecast
The average price target for ABBV is $205.5, which is 13.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $205.5 |
| Price Target Difference | 13.4% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
Scores
| Altman Z-Score | 1.96 |
| Piotroski F-Score | 5 |